The Power of Two: Expanding FDA-designated Nanotechnology in Implants

In our 2025 OMTEC presentation, Nanovis highlighted the defining features of our FDA-designated nanotechnology, nanoVIS Ti, including how nanoscale surface properties influence biological response, our Four Pillars of Healing framework, partner adoption, and how we streamline customer integration from development through commercialization. We concluded by referencing additional nanotechnologies in development.  

At OMTEC 2026, Nanovis will officially launch a new nanotechnology and show how our platform is expanding beyond a single surface solution. The presentation will compare key features of the new surface to nanoVIS Ti; explain how the Four Pillars of Healing apply; and outline regulatory progress and early partnership opportunities, including the ability to be among the first to commercialize this technology. With this launch, Nanovis will become the only company offering two FDA-designated nanotechnologies for implant surfaces. 

Attend this session by Nanovis in Booth 746.